[go: up one dir, main page]

NO20055582D0 - Compositions and Methods comprising Gastrin Compounds - Google Patents

Compositions and Methods comprising Gastrin Compounds

Info

Publication number
NO20055582D0
NO20055582D0 NO20055582A NO20055582A NO20055582D0 NO 20055582 D0 NO20055582 D0 NO 20055582D0 NO 20055582 A NO20055582 A NO 20055582A NO 20055582 A NO20055582 A NO 20055582A NO 20055582 D0 NO20055582 D0 NO 20055582D0
Authority
NO
Norway
Prior art keywords
compositions
methods
gastrin compounds
gastrin
compounds
Prior art date
Application number
NO20055582A
Other languages
Norwegian (no)
Other versions
NO20055582L (en
Inventor
Antonio Cruz
Original Assignee
Waratah Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2003/016660 external-priority patent/WO2003100024A2/en
Application filed by Waratah Pharmaceuticals Inc filed Critical Waratah Pharmaceuticals Inc
Publication of NO20055582D0 publication Critical patent/NO20055582D0/en
Publication of NO20055582L publication Critical patent/NO20055582L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/2207Gastrins; Cholecystokinins [CCK]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO20055582A 2003-05-27 2005-11-25 Compositions and Methods comprising Gastrin Compounds NO20055582L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2003/016660 WO2003100024A2 (en) 2002-05-24 2003-05-27 Treatment for diabetes
PCT/CA2004/000769 WO2004105780A2 (en) 2003-05-27 2004-05-27 Compositions comprising gastrin compounds and their use in diabetes

Publications (2)

Publication Number Publication Date
NO20055582D0 true NO20055582D0 (en) 2005-11-25
NO20055582L NO20055582L (en) 2006-02-27

Family

ID=33488788

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055582A NO20055582L (en) 2003-05-27 2005-11-25 Compositions and Methods comprising Gastrin Compounds

Country Status (11)

Country Link
EP (1) EP1648495A2 (en)
JP (1) JP2007513059A (en)
CN (1) CN1829528A (en)
AU (1) AU2004243541A1 (en)
BR (1) BRPI0410710A (en)
CA (1) CA2527186A1 (en)
MX (1) MXPA05012605A (en)
NO (1) NO20055582L (en)
PL (1) PL379145A1 (en)
RU (1) RU2005140518A (en)
WO (1) WO2004105780A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004520345A (en) 2001-01-12 2004-07-08 ワラター・ファーマシューティカルズ・インク Sustained effect of islet cell neoplasia treatment method using gastrin / CCK receptor ligand and EGF receptor ligand composition for subjects with diabetes
JP2005533775A (en) 2002-06-07 2005-11-10 ワラタ ファーマシューティカルズ, インコーポレイテッド Compositions and methods for treating diabetes
EP1837031B1 (en) 2002-06-07 2009-10-14 Waratah Pharmaceuticals, Inc. Compositions and methods for treating diabetes
AU2005207870B2 (en) * 2004-01-30 2010-08-19 Waratah Pharmaceuticals, Inc. The combined use of GLP-1 agonists and gastrin for regulating blood glucose levels
WO2008106779A1 (en) * 2007-03-02 2008-09-12 Waratah Pharmaceuticals Inc. Gastrin compound for diabetes treatment

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6558952B1 (en) * 1992-12-14 2003-05-06 Waratah Pharmaceuticals, Inc. Treatment for diabetes
CA2182034C (en) * 1994-01-24 2009-04-21 Ronald V. Nardi Treatment for juvenile diabetes
JP2004520345A (en) * 2001-01-12 2004-07-08 ワラター・ファーマシューティカルズ・インク Sustained effect of islet cell neoplasia treatment method using gastrin / CCK receptor ligand and EGF receptor ligand composition for subjects with diabetes
BR0315523A (en) * 2002-10-22 2005-08-30 Waratah Pharmaceuticals Inc Diabetes treatment

Also Published As

Publication number Publication date
MXPA05012605A (en) 2006-02-22
EP1648495A2 (en) 2006-04-26
WO2004105780A3 (en) 2005-01-20
NO20055582L (en) 2006-02-27
PL379145A1 (en) 2006-07-24
BRPI0410710A (en) 2006-06-13
JP2007513059A (en) 2007-05-24
WO2004105780A2 (en) 2004-12-09
RU2005140518A (en) 2007-07-10
AU2004243541A1 (en) 2004-12-09
CA2527186A1 (en) 2004-12-09
CN1829528A (en) 2006-09-06

Similar Documents

Publication Publication Date Title
DE602004031845D1 (en) NG
NO20055837D0 (en) Immunosuppressants and Compositions
DK1592686T3 (en) Gyrase Inhibitors and Uses thereof
NO20032220D0 (en) Löfteverktöy II and method for using the same
DE502004011133D1 (en) UTEILS
IS8320A (en) N-substituted pyrazolyl-amidyl-benzimidazolyl
DE602004004904D1 (en) NUANCIERUNGSMITTEL
DE602004018837D1 (en) PTIDASE-IV INHIBITORS
DE602004000356T8 (en) Connectors
SE0302091L (en) Implementation
AT502792A5 (en) DÜSENANPRESSVORRICHTUNG
DE502004002085D1 (en) Multiple insertion
DK1601744T3 (en) ENGINEERING AND PROCEDURE
DE502004008321D1 (en) BANDAUFWICKELVERFAHREN
DE602004016676D1 (en) Gasflüssigkeitsabscheider
IS8273A (en) New equipment
DE602004018799D1 (en) NG
DE602004009212D1 (en) FLUIDSTRAHLBOHRWERKZEUG
DE602004009257D1 (en) Bremsschlauchanordung
IS8489A (en) Transcriptors and their methods
ATE514681T1 (en) N-SUBSTITUTED PYRAZOLYLCARBOXANILIDES
DE602004010064D1 (en) FREILAUF KUPPLUNGSFEDER
NO20032330L (en) Plug
NO20055582D0 (en) Compositions and Methods comprising Gastrin Compounds
DE10394329D2 (en) Mäanderstent

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application